Hainan Shuangcheng Pharmaceuticals Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 250.33 million compared to CNY 303.56 million a year ago. Revenue was CNY 274.75 million compared to CNY 320.29 million a year ago.

Net income was CNY 9.01 million compared to net loss of CNY 20.33 million a year ago. Basic earnings per share from continuing operations was CNY 0.02 compared to basic loss per share from continuing operations of CNY 0.05 a year ago. Diluted earnings per share from continuing operations was CNY 0.02 compared to diluted loss per share from continuing operations of CNY 0.05 a year ago.